Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources

<b>Background</b>: Myocarditis and pericarditis are recognised risks following COVID-19 vaccination, including the mRNA-1273 vaccine. Most cases occur shortly following the second dose of this vaccine, and incidence is highest among young males. However, little is known about risk factors beyond age...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Laura C. Zwiers, Diederick E. Grobbee, Rob Schneijdenberg, Corine Baljé, Samantha St. Laurent, Daina B. Esposito, Lei Zhu, Veronica V. Urdaneta, Magalie Emilebacker, Daniel Weibel, Felipe Villalobos, Carlo Alberto Bissacco, Arantxa Urchueguía Fornes, Juan José Carreras-Martínez, Anteneh A. Desalegn, Angela Lupattelli, Lei Wang, Jannik Wheler, Vera Ehrenstein, Denise Morris, Catherine Fry, Marjolein Jansen, Brianna M. Goodale, David S. Y. Ong
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2025-07-01
Seri Bilgileri:	Vaccines
Konular:	myocarditis pericarditis vaccination COVID-19 vaccines safety
Online Erişim:	https://www.mdpi.com/2076-393X/13/7/755
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!